In vitro Study of a Novel Stent Coating Using Modified CD39 Messenger RNA to Potentially Reduce Stent Angioplasty-Associated Complications

• Meike-Kristin Abraham,

  Affiliation Department of Thoracic, Cardiac and Vascular Surgery, Clinical Research Laboratory, University Hospital Tuebingen, Teubingen, Germany

  ⨯
• Andrea Nolte ,

  * E-mail: andrea.nolte@thg-lab.de

  Affiliation Department of Thoracic, Cardiac and Vascular Surgery, Clinical Research Laboratory, University Hospital Tuebingen, Teubingen, Germany

  ⨯
• Rebekka Reus,

  Affiliation Department of Thoracic, Cardiac and Vascular Surgery, Clinical Research Laboratory, University Hospital Tuebingen, Teubingen, Germany

  ⨯
• Andreas Behring,

  Affiliation Department of Thoracic, Cardiac and Vascular Surgery, Clinical Research Laboratory, University Hospital Tuebingen, Teubingen, Germany

  ⨯
• Diane Zengerle,

  Affiliation Department of Thoracic, Cardiac and Vascular Surgery, Clinical Research Laboratory, University Hospital Tuebingen, Teubingen, Germany

  ⨯
• Meltem Avci-Adali,

  Affiliation Department of Thoracic, Cardiac and Vascular Surgery, Clinical Research Laboratory, University Hospital Tuebingen, Teubingen, Germany

  ⨯
• Jan David Hohmann,

  Affiliation Atherothrombosis and Vascular Biology, Baker IDI Heart & Diabetes Institute, Melbourne, Victoria, Australia

  ⨯
• Karlheinz Peter,

  Affiliation Atherothrombosis and Vascular Biology, Baker IDI Heart & Diabetes Institute, Melbourne, Victoria, Australia

  ⨯
• Christian Schlensak,

  Affiliation Department of Thoracic, Cardiac and Vascular Surgery, Clinical Research Laboratory, University Hospital Tuebingen, Teubingen, Germany

  ⨯
• Hans Peter Wendel,

  Affiliation Department of Thoracic, Cardiac and Vascular Surgery, Clinical Research Laboratory, University Hospital Tuebingen, Teubingen, Germany

  ⨯
• Stefanie Krajewski

  Affiliation Department of Thoracic, Cardiac and Vascular Surgery, Clinical Research Laboratory, University Hospital Tuebingen, Teubingen, Germany

  ⨯